about
Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazoleIncreased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activityCatalysis and Sulfa Drug Resistance in Dihydropteroate SynthaseThe identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinaseMulticenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumoniaManagement of acneManagement of community-associated methicillin-resistant Staphylococcus aureus infections in children.Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.The evolving role of chemical synthesis in antibacterial drug discovery.Immunological principles of T-cell-mediated adverse drug reactions in skin.Replacing sulfa drugs with novel DHPS inhibitorsChronic administration of oral trimethoprim-sulfamethoxazole for acne vulgaris.Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease.Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients.Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement.An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital.Urinary tract infections and reduced risk of bladder cancer in Los Angeles.Severe Agranulocytosis following Simultaneous Administration of Chlorpromazine and Trimethoprim-Sulfamethoxazole in a Patient with Sepsis: A Possible Toxic Combination.Newer developments in the treatment of Gram-positive infections.Community-Associated Methicillin-Resistant Staphylococcus aureus in the Pediatric Population.Is repositioning of drugs a viable alternative in the treatment of tuberculosis?The potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis.Artemisinin and its derivatives in treating protozoan infections beyond malaria.In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii.Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant TuberculosisPneumocystis pneumonia complicating immunosuppressive therapy in Crohns disease: A preventable problem?Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.46-year-old man with fevers, chills, and pancytopenia.Friendly fire.Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.Digital Quantification of DNA Replication and Chromosome Segregation Enables Determination of Antimicrobial Susceptibility after only 15 Minutes of Antibiotic Exposure.Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance.A mathematical model of microbial folate biosynthesis and utilisation: implications for antifolate development.Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.Cotrimoxazole-induced hypoglycaemia in a patient with churg-strauss syndromeOnline solid-phase extraction-liquid chromatography-electrospray-tandem mass spectrometry determination of multiple classes of antibiotics in environmental and treated waters.Myelotoxicity due to methotrexate - an iatrogenic cause.Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole.Probable trimethoprim/sulfamethoxazole-induced higher-level gait disorder and nocturnal delirium in an elderly man.
P2860
Q24620644-CB7C70E4-7D8F-4F28-A0C5-066EE8EE22EDQ27653751-0FC906DD-7290-4D3B-9D00-4F02D82BE662Q27677575-FE2C1F06-F80E-4B35-BD9A-361D5A3024DBQ27682055-85EB7658-3911-4266-9CC4-6E5CB7313236Q28542714-172805B6-E36A-454A-8525-69D42BFDDD54Q28972546-6804CF6B-44E1-443C-BEC1-95CFDB454DF2Q33264579-7DF541E4-3BB8-44F5-AE84-A20C807D6940Q34402839-E9C14854-21A1-4657-A25F-5BC99D69DEAAQ34427652-FB2F1D48-79A7-4B4C-8A51-7E2D81351135Q34609440-B7757C23-6D3F-4092-8112-61F1848EFEFFQ34823402-78DB6566-0E34-4C56-A75D-43054B601650Q35200084-A3244F78-F7EB-4987-982E-86C6E93014B4Q35598594-F773636E-D98C-47C7-B7B4-301EF20C74A2Q35959278-7873C126-59DD-4EB1-8DA5-2AE72B1FE306Q36428422-27990194-5BA4-4231-9524-15C512B22BADQ36464204-259C6381-24D7-4854-96F7-27F4AEBBE5B6Q36616349-93CB7504-7F98-446D-B3D5-F2E4BB954026Q37123550-3D860610-2000-4B11-A9D9-EDE27029AF59Q37382480-4ADB22B3-0430-47AD-BBFD-BB16A6F80C06Q37636151-6FB3EF9B-92F7-42FA-9F7D-8A9A57085551Q38051319-371292EF-68C0-41AA-87C9-137E79B845C8Q38053000-0EC641A2-E6B8-4C9E-A034-6F364E6DD991Q38806183-7C7DEE3A-50BA-440E-A9CE-489F85DF5A8EQ39014776-FEB61876-16FE-4A1B-BBD6-1800B3D76E4FQ39027347-39D9FC13-AFF2-45E5-B2EE-810F1A363BB0Q39030684-8181FCEC-C2B5-47E2-A26C-6D0F92E550E0Q40080089-44DBA090-7FAC-427B-9639-E3F961E85CF0Q40092648-FA89D11F-8D13-4F08-B775-3B6411AFB617Q40278694-EB34E0EC-8462-4F8B-B814-DCA942E1E063Q40335873-89651692-654B-4E24-9850-D5D132600929Q40375985-38C8350E-1E3F-4C05-A524-FB98A756D07EQ40385875-2BC9CAC6-B56D-4C69-B049-4525BA1C4528Q40448254-9F79B3BD-B07C-4F16-8258-C977F51E0067Q40823145-0981DBC5-5798-403D-90A6-F522D69924CDQ41870463-492BB0EF-42E7-4E94-A99E-138344396E3FQ41916961-E4E7C792-491E-4BB8-98CE-CED5890F5E35Q43356023-3F69881B-6F2F-4EBC-959F-61B9C562F5B7Q44569940-F080BF2F-F45C-4401-8026-F4173A0CB0D7Q44606124-69A48648-D04B-4491-9EF6-5914662F4D15Q46183143-FD06BAF1-B8AB-4198-9365-50D1FAD14568
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Trimethoprim-sulfamethoxazole revisited.
@ast
Trimethoprim-sulfamethoxazole revisited.
@en
Trimethoprim-sulfamethoxazole revisited.
@nl
type
label
Trimethoprim-sulfamethoxazole revisited.
@ast
Trimethoprim-sulfamethoxazole revisited.
@en
Trimethoprim-sulfamethoxazole revisited.
@nl
prefLabel
Trimethoprim-sulfamethoxazole revisited.
@ast
Trimethoprim-sulfamethoxazole revisited.
@en
Trimethoprim-sulfamethoxazole revisited.
@nl
P2093
P1476
Trimethoprim-sulfamethoxazole revisited.
@en
P2093
Debra Q Miller
John Zurlo
Nirmal Joshi
Philip A Masters
Thomas A O'Bryan
P304
P356
10.1001/ARCHINTE.163.4.402
P407
P577
2003-02-01T00:00:00Z